The association of symptomatic vitreous floaters with depression and anxiety.
Anxiety
Depression
Floaters
HADS
PHQ-9, Zung SDS
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
07 May 2024
07 May 2024
Historique:
received:
20
08
2023
accepted:
19
10
2023
medline:
7
5
2024
pubmed:
7
5
2024
entrez:
7
5
2024
Statut:
epublish
Résumé
To evaluate the levels of anxiety and depression in patients with symptomatic vitreous floaters and to determine the possible correlations of psychological implications with the symptoms duration and possible improvement, the degree of posterior vitreous detachment, and the discomfort severity. Ninety patients complaining for floaters and fifty-seven age- and gender-matched healthy-control subjects were recruited. Every participant underwent a complete ophthalmological examination, including funduscopy and optical coherence tomography scans, while clinical and demographic data were also gathered. The Patient Health Questionnaire-9 (PHQ-9), the Zung Depression Inventory-Self-Rating Depression Scale (Zung SDS), and the Hospital Anxiety and Depression Scale (HADS) were completed by everyone. Between the studied groups, no significant differences were detected regarding the clinical and demographic data (p > 0.05). The patients with floaters had significantly higher scores of PHQ-9, Zung SDS, HADS Anxiety, and HADS Depression (p < 0.001). After adjustment for several confounders, PHQ-9 (p = 0.041), Zung SDS (p = 0.003), and HADS Anxiety (p = 0.036) values remained significantly impaired. Among the patients, PHQ-9 and Zung SDS scores were significantly elevated in the patients with floaters duration less than 4 weeks (p < 0.05). Finally, anxiety and depression were significantly correlated with the symptoms duration and intensity, with the floater-associated discomfort, and with the stage of posterior vitreous detachment. Vitreous floaters have a negative impact on patients' psychological status, by the terms of enhanced depressive and anxiety levels. To the best of our knowledge, our study is the first in the literature to elaborate the aforementioned association, by assessing three different questionnaires simultaneously.
Identifiants
pubmed: 38713290
doi: 10.1007/s10792-024-03006-y
pii: 10.1007/s10792-024-03006-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
218Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Milston R, Madigan MC, Sebag J (2016) Vitreous floaters: Etiology, diagnostics, and management. Surv Ophthalmol 61:211–227. https://doi.org/10.1016/j.survophthal.2015.11.008
doi: 10.1016/j.survophthal.2015.11.008
pubmed: 26679984
Wagle AM, Lim WY, Yap TP, Neelam K, Au Eong KG (2011) Utility values associated with vitreous floaters. Am J Ophthalmol 152:60-65.e1. https://doi.org/10.1016/j.ajo.2011.01.026
doi: 10.1016/j.ajo.2011.01.026
pubmed: 21570045
Gishti O, van den Nieuwenhof R, Verhoekx J, van Overdam K (2019) Symptoms related to posterior vitreous detachment and the risk of developing retinal tears: a systematic review. Acta Ophthalmol 97:347–352. https://doi.org/10.1111/aos.14012
doi: 10.1111/aos.14012
pubmed: 30632695
Roufail ED, Polkinghorne P (2006) Vitreous floaters. Compr Ophthalmol Update 7:171–177
pubmed: 17007730
Sebag J (2011) Floaters and the quality of life. Am J Ophthalmol 152:3-4.e1. https://doi.org/10.1016/j.ajo.2011.02.015
doi: 10.1016/j.ajo.2011.02.015
pubmed: 21703388
Byer NE (1994) Natural history of posterior vitreous detachment with early management as the premier line of defense against retinal detachment. Ophthalmology 101:1503–1514. https://doi.org/10.1016/s0161-6420(94)31141-9
doi: 10.1016/s0161-6420(94)31141-9
pubmed: 8090453
Garcia GA, Khoshnevis M, Yee KMP, Nguyen-Cuu J, Nguyen JH, Sebag J (2016) Degradation of Contrast Sensitivity Function Following Posterior Vitreous Detachment. Am J Ophthalmol 172:7–12. https://doi.org/10.1016/j.ajo.2016.09.005
doi: 10.1016/j.ajo.2016.09.005
pubmed: 27633841
Khoshnevis M, Nguyen-Cuu J, Sebag J (2016) Floaters and reduced contrast sensitivity after successful pharmacologic vitreolysis with ocriplasmin. Am J Ophthalmol Case Rep 4:54–56. https://doi.org/10.1016/j.ajoc.2016.08.005
doi: 10.1016/j.ajoc.2016.08.005
pubmed: 29503926
Kim YK, Moon SY, Yim KM, Seong SJ, Hwang JY, Park SP (2017) Psychological Distress in Patients with Symptomatic Vitreous Floaters. J Ophthalmol 2017:3191576. https://doi.org/10.1155/2017/3191576
doi: 10.1155/2017/3191576
pubmed: 29375909
Senra H, Ali Z, Aslam T, Patton N (2022) Psychological implications of vitreous opacities - A systematic review. J Psychosom Res 154:110729. https://doi.org/10.1016/j.jpsychores.2022.110729
doi: 10.1016/j.jpsychores.2022.110729
pubmed: 35091262
Moschos MM, Gouliopoulos NS, Kalogeropoulos C, Androudi S, Kitsos G, Ladas D, Tsatsos M, Chatziralli I (2018) Psychological Aspects and Depression in Patients with Symptomatic Keratoconus. J Ophthalmol 2018:7314308. https://doi.org/10.1155/2018/7314308
doi: 10.1155/2018/7314308
pubmed: 30002924
pmcid: 5996428
Hu Y, Deng F, Zhang L, Hu K, Liu S, Zhong S, Yang J, Zeng X, Peng X (2022) Depression and Quality of Life in Patients with Gliomas: A Narrative Review. J Clin Med 11:4811. https://doi.org/10.3390/jcm11164811
doi: 10.3390/jcm11164811
pubmed: 36013047
pmcid: 9410515
Del Piccolo L, Saltini A, Zimmermann C (1998) Which patients talk about stressful life events and social problems to the general practitioner? Psychol Med 28:1289–1299. https://doi.org/10.1017/s0033291798007478
doi: 10.1017/s0033291798007478
pubmed: 9854270
Mitchell AJ, Vaze A, Rao S (2009) Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 374:609–619. https://doi.org/10.1016/S0140-6736(09)60879-5
doi: 10.1016/S0140-6736(09)60879-5
pubmed: 19640579
Williams JW Jr, Kerber CA, Mulrow CD, Medina A, Aguilar C (1995) Depressive disorders in primary care: prevalence, functional disability, and identification. J Gen Intern Med 10:7–12. https://doi.org/10.1007/BF02599568
doi: 10.1007/BF02599568
pubmed: 7699487
Penninx BW, Pine DS, Holmes EA, Reif A (2021) Anxiety disorders. Lancet 397:914–927. https://doi.org/10.1016/S0140-6736(21)00359-7
doi: 10.1016/S0140-6736(21)00359-7
pubmed: 33581801
Stern AF (2014) The hospital anxiety and depression scale. Occup Med (Lond) 64:393–394. https://doi.org/10.1093/occmed/kqu024
doi: 10.1093/occmed/kqu024
pubmed: 25005549
García BG, Orduna Magán C, Alvarez-Peregrina C, Villa-Collar C, Sánchez-Tena MÁ (2021) Nd:YAG laser vitreolysis and health-related quality of life in patients with symptomatic vitreous floaters. Eur J Ophthalmol. https://doi.org/10.1177/11206721211008036
doi: 10.1177/11206721211008036
pubmed: 33827286
Wu RH, Jiang JH, Gu YF, Moonasar N, Lin Z (2020) Pars plana vitrectomy relieves the depression in patients with symptomatic vitreous floaters. Int J Ophthalmol 13:412–416. https://doi.org/10.18240/ijo.2020.03.07
doi: 10.18240/ijo.2020.03.07
pubmed: 32309177
pmcid: 7154191
Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
doi: 10.1046/j.1525-1497.2001.016009606.x
pubmed: 11556941
pmcid: 1495268
Zung WW (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63–70. https://doi.org/10.1001/archpsyc.1965.01720310065008
doi: 10.1001/archpsyc.1965.01720310065008
pubmed: 14221692
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
doi: 10.1111/j.1600-0447.1983.tb09716.x
pubmed: 6880820
Gouliopoulos N, Siasos G, Moschos MM, Oikonomou E, Rouvas A, Bletsa E, Stampouloglou P, Siasou G, Paraskevopoulos T, Vlasis K, Marinos G, Tousoulis D (2020) Endothelial dysfunction and impaired arterial wall properties in patients with retinal vein occlusion. Vasc Med 25:302–308. https://doi.org/10.1177/1358863X20913609
doi: 10.1177/1358863X20913609
pubmed: 32308146
Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire JAMA 282:1737–1744. https://doi.org/10.1001/jama.282.18.1737
doi: 10.1001/jama.282.18.1737
pubmed: 10568646
Spitzer RL, Williams JB, Kroenke K, Hornyak R, McMurray J (2000) Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD patient health questionnaire obstetrics-gynecology study. Am J Obstet Gynecol 183:759–769. https://doi.org/10.1067/mob.2000.106580
doi: 10.1067/mob.2000.106580
pubmed: 10992206
Kroenke K, Spitzer RL, Williams JB, Löwe B (2010) The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry 32:345–359. https://doi.org/10.1016/j.genhosppsych.2010.03.006
doi: 10.1016/j.genhosppsych.2010.03.006
pubmed: 20633738
Chacón-López H, Pelayo FJ, López-Justicia MD, Morillas CA, Ureña R, Chacón-Medina A, Pino B (2013) Visual training and emotional state of people with retinitis pigmentosa. J Rehabil Res Dev 50:1157–1168. https://doi.org/10.1682/JRRD.2012.06.0113
doi: 10.1682/JRRD.2012.06.0113
pubmed: 24458902
Jokelainen J, Timonen M, Keinänen-Kiukaanniemi S, Härkönen P, Jurvelin H, Suija K (2019) Validation of the Zung self-rating depression scale (SDS) in older adults. Scand J Prim Health Care 37:353–357. https://doi.org/10.1080/02813432.2019.1639923
doi: 10.1080/02813432.2019.1639923
pubmed: 31286810
pmcid: 6713148
Branch LG, Horowitz A, Carr C (1989) The implications for everyday life of incident self-reported visual decline among people over age 65 living in the community. Gerontologist 29:359–365. https://doi.org/10.1093/geront/29.3.359
doi: 10.1093/geront/29.3.359
pubmed: 2788109
Buch H, Vinding T, La Cour M, Appleyard M, Jensen GB, Nielsen NV (2004) Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen city Eye Study. Ophthalmology 111:53–61. https://doi.org/10.1016/j.ophtha.2003.05.010
doi: 10.1016/j.ophtha.2003.05.010
pubmed: 14711714
Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368:1795–1809. https://doi.org/10.1016/S0140-6736(06)69740-7
doi: 10.1016/S0140-6736(06)69740-7
pubmed: 17113430
Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52:69–77. https://doi.org/10.1016/s0022-3999(01)00296-3
doi: 10.1016/s0022-3999(01)00296-3
pubmed: 11832252
Torrance GW, Feeny D (1989) Utilities and quality-adjusted life years. Int J Technol Assess Health Care 5:559–575. https://doi.org/10.1017/s0266462300008461
doi: 10.1017/s0266462300008461
pubmed: 2634630
Stein JD, Brown GC, Brown MM, Sharma S, Hollands H, Stein HD (2002) The quality of life of patients with hypertension. J Clin Hypertens 4:181–188. https://doi.org/10.1111/j.1524-6175.2002.00970.x
doi: 10.1111/j.1524-6175.2002.00970.x
Duncan PW, Lai SM, Keighley J (2000) Defining post-stroke recovery: implications for design and interpretation of drug trials. Neuropharmacology 39:835–841
doi: 10.1016/S0028-3908(00)00003-4
pubmed: 10699448
Smith RD, Hall J, Gurney H, Harnett PR (1993) A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant therapy for Duke’s C colonic cancer. Med J Aust 158:319–322. https://doi.org/10.1016/s0028-3908(00)00003-4
doi: 10.1016/s0028-3908(00)00003-4
pubmed: 8474372
Tsevat J, Solzan JG, Kuntz KM, Ragland J, Currier JS, Sell RL, Weinstein MC (1996) Health values of patients infected with HIV. Relationship to mental health and physical functioning. Med Care 34:44–57. https://doi.org/10.1097/00005650-199601000-00004
doi: 10.1097/00005650-199601000-00004
pubmed: 8551811
Wada K, Tanaka K, Theriault G, Satoh T, Mimura M, Miyaoka H, Aizawa Y (2007) Validity of the Center for Epidemiologic Studies Depression Scale as a screening instrument of major depressive disorder among Japanese workers. Am J Ind Med 50:8–12. https://doi.org/10.1002/ajim.20403
doi: 10.1002/ajim.20403
pubmed: 17096372
Noble RE (2005) Depression in women. Metabolism 54:49–52. https://doi.org/10.1016/j.metabol.2005.01.014
doi: 10.1016/j.metabol.2005.01.014
pubmed: 15877314